nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CHRM3—muscle of abdomen—muscle cancer	0.0213	0.399	CbGeAlD
Cevimeline—FMO1—renal system—muscle cancer	0.00572	0.107	CbGeAlD
Cevimeline—FMO1—tendon—muscle cancer	0.00447	0.0837	CbGeAlD
Cevimeline—FMO1—vagina—muscle cancer	0.00415	0.0777	CbGeAlD
Cevimeline—FMO1—head—muscle cancer	0.00383	0.0718	CbGeAlD
Cevimeline—CHRM3—smooth muscle tissue—muscle cancer	0.00244	0.0458	CbGeAlD
Cevimeline—CHRM3—renal system—muscle cancer	0.00235	0.0441	CbGeAlD
Cevimeline—CHRM1—head—muscle cancer	0.00176	0.033	CbGeAlD
Cevimeline—CHRM3—head—muscle cancer	0.00157	0.0295	CbGeAlD
Cevimeline—CHRM3—testis—muscle cancer	0.00152	0.0285	CbGeAlD
Cevimeline—Renal impairment—Doxorubicin—muscle cancer	0.00129	0.00137	CcSEcCtD
Cevimeline—CYP3A4—renal system—muscle cancer	0.00129	0.0242	CbGeAlD
Cevimeline—Paraesthesia—Vincristine—muscle cancer	0.00129	0.00136	CcSEcCtD
Cevimeline—Malaise—Etoposide—muscle cancer	0.00129	0.00136	CcSEcCtD
Cevimeline—Dermatitis bullous—Doxorubicin—muscle cancer	0.00129	0.00136	CcSEcCtD
Cevimeline—Vertigo—Etoposide—muscle cancer	0.00128	0.00136	CcSEcCtD
Cevimeline—Leukopenia—Etoposide—muscle cancer	0.00128	0.00135	CcSEcCtD
Cevimeline—Purpura—Doxorubicin—muscle cancer	0.00128	0.00135	CcSEcCtD
Cevimeline—Abdominal pain—Dactinomycin—muscle cancer	0.00127	0.00134	CcSEcCtD
Cevimeline—Body temperature increased—Dactinomycin—muscle cancer	0.00127	0.00134	CcSEcCtD
Cevimeline—CYP2D6—renal system—muscle cancer	0.00127	0.0238	CbGeAlD
Cevimeline—Hypoglycaemia—Doxorubicin—muscle cancer	0.00126	0.00133	CcSEcCtD
Cevimeline—Loss of consciousness—Etoposide—muscle cancer	0.00126	0.00133	CcSEcCtD
Cevimeline—Decreased appetite—Vincristine—muscle cancer	0.00125	0.00132	CcSEcCtD
Cevimeline—Cough—Etoposide—muscle cancer	0.00125	0.00132	CcSEcCtD
Cevimeline—Fatigue—Vincristine—muscle cancer	0.00124	0.00131	CcSEcCtD
Cevimeline—Convulsion—Etoposide—muscle cancer	0.00124	0.00131	CcSEcCtD
Cevimeline—Hyponatraemia—Doxorubicin—muscle cancer	0.00123	0.0013	CcSEcCtD
Cevimeline—Hypertension—Etoposide—muscle cancer	0.00123	0.0013	CcSEcCtD
Cevimeline—Pain—Vincristine—muscle cancer	0.00123	0.0013	CcSEcCtD
Cevimeline—Constipation—Vincristine—muscle cancer	0.00123	0.0013	CcSEcCtD
Cevimeline—Osteoarthritis—Doxorubicin—muscle cancer	0.00123	0.0013	CcSEcCtD
Cevimeline—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00123	0.0013	CcSEcCtD
Cevimeline—Pain in extremity—Doxorubicin—muscle cancer	0.00123	0.0013	CcSEcCtD
Cevimeline—Diplopia—Doxorubicin—muscle cancer	0.00123	0.0013	CcSEcCtD
Cevimeline—Asthma—Methotrexate—muscle cancer	0.00123	0.0013	CcSEcCtD
Cevimeline—Chest pain—Etoposide—muscle cancer	0.00122	0.00128	CcSEcCtD
Cevimeline—Eosinophilia—Methotrexate—muscle cancer	0.00122	0.00128	CcSEcCtD
Cevimeline—Affect lability—Doxorubicin—muscle cancer	0.00121	0.00128	CcSEcCtD
Cevimeline—Migraine—Doxorubicin—muscle cancer	0.00121	0.00128	CcSEcCtD
Cevimeline—Discomfort—Etoposide—muscle cancer	0.0012	0.00127	CcSEcCtD
Cevimeline—Face oedema—Doxorubicin—muscle cancer	0.00119	0.00125	CcSEcCtD
Cevimeline—Hypersensitivity—Dactinomycin—muscle cancer	0.00119	0.00125	CcSEcCtD
Cevimeline—Gastrointestinal pain—Vincristine—muscle cancer	0.00118	0.00124	CcSEcCtD
Cevimeline—Confusional state—Etoposide—muscle cancer	0.00118	0.00124	CcSEcCtD
Cevimeline—Mood swings—Doxorubicin—muscle cancer	0.00117	0.00123	CcSEcCtD
Cevimeline—Infection—Etoposide—muscle cancer	0.00116	0.00122	CcSEcCtD
Cevimeline—Asthenia—Dactinomycin—muscle cancer	0.00116	0.00122	CcSEcCtD
Cevimeline—Dysuria—Methotrexate—muscle cancer	0.00115	0.00121	CcSEcCtD
Cevimeline—Dehydration—Doxorubicin—muscle cancer	0.00114	0.00121	CcSEcCtD
Cevimeline—Thrombocytopenia—Etoposide—muscle cancer	0.00114	0.00121	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00114	0.00121	CcSEcCtD
Cevimeline—Tachycardia—Etoposide—muscle cancer	0.00114	0.0012	CcSEcCtD
Cevimeline—Abdominal pain—Vincristine—muscle cancer	0.00114	0.0012	CcSEcCtD
Cevimeline—Body temperature increased—Vincristine—muscle cancer	0.00114	0.0012	CcSEcCtD
Cevimeline—Skin disorder—Etoposide—muscle cancer	0.00113	0.0012	CcSEcCtD
Cevimeline—Erectile dysfunction—Methotrexate—muscle cancer	0.00113	0.00119	CcSEcCtD
Cevimeline—Dry skin—Doxorubicin—muscle cancer	0.00113	0.00119	CcSEcCtD
Cevimeline—Hyperhidrosis—Etoposide—muscle cancer	0.00113	0.00119	CcSEcCtD
Cevimeline—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00112	0.00119	CcSEcCtD
Cevimeline—Photosensitivity reaction—Methotrexate—muscle cancer	0.00112	0.00118	CcSEcCtD
Cevimeline—Hypokalaemia—Doxorubicin—muscle cancer	0.00112	0.00118	CcSEcCtD
Cevimeline—Anorexia—Etoposide—muscle cancer	0.00111	0.00117	CcSEcCtD
Cevimeline—Diarrhoea—Dactinomycin—muscle cancer	0.0011	0.00116	CcSEcCtD
Cevimeline—Pneumonia—Methotrexate—muscle cancer	0.0011	0.00116	CcSEcCtD
Cevimeline—Depression—Methotrexate—muscle cancer	0.00109	0.00115	CcSEcCtD
Cevimeline—Hypotension—Etoposide—muscle cancer	0.00109	0.00115	CcSEcCtD
Cevimeline—Gastritis—Doxorubicin—muscle cancer	0.00109	0.00115	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00108	0.00115	CcSEcCtD
Cevimeline—Muscular weakness—Doxorubicin—muscle cancer	0.00108	0.00115	CcSEcCtD
Cevimeline—Abdominal distension—Doxorubicin—muscle cancer	0.00107	0.00113	CcSEcCtD
Cevimeline—Stomatitis—Methotrexate—muscle cancer	0.00107	0.00113	CcSEcCtD
Cevimeline—Conjunctivitis—Methotrexate—muscle cancer	0.00106	0.00112	CcSEcCtD
Cevimeline—Asthma—Doxorubicin—muscle cancer	0.00106	0.00112	CcSEcCtD
Cevimeline—Dysphagia—Doxorubicin—muscle cancer	0.00106	0.00112	CcSEcCtD
Cevimeline—Hypersensitivity—Vincristine—muscle cancer	0.00106	0.00112	CcSEcCtD
Cevimeline—Eosinophilia—Doxorubicin—muscle cancer	0.00105	0.00111	CcSEcCtD
Cevimeline—Paraesthesia—Etoposide—muscle cancer	0.00105	0.00111	CcSEcCtD
Cevimeline—Haematuria—Methotrexate—muscle cancer	0.00104	0.0011	CcSEcCtD
Cevimeline—Dyspnoea—Etoposide—muscle cancer	0.00104	0.0011	CcSEcCtD
Cevimeline—Somnolence—Etoposide—muscle cancer	0.00104	0.00109	CcSEcCtD
Cevimeline—Angina pectoris—Doxorubicin—muscle cancer	0.00104	0.00109	CcSEcCtD
Cevimeline—Epistaxis—Methotrexate—muscle cancer	0.00103	0.00109	CcSEcCtD
Cevimeline—Asthenia—Vincristine—muscle cancer	0.00103	0.00109	CcSEcCtD
Cevimeline—Vomiting—Dactinomycin—muscle cancer	0.00102	0.00108	CcSEcCtD
Cevimeline—Bronchitis—Doxorubicin—muscle cancer	0.00102	0.00108	CcSEcCtD
Cevimeline—Agranulocytosis—Methotrexate—muscle cancer	0.00102	0.00108	CcSEcCtD
Cevimeline—Rash—Dactinomycin—muscle cancer	0.00102	0.00107	CcSEcCtD
Cevimeline—Decreased appetite—Etoposide—muscle cancer	0.00101	0.00107	CcSEcCtD
Cevimeline—Fatigue—Etoposide—muscle cancer	0.001	0.00106	CcSEcCtD
Cevimeline—Pain—Etoposide—muscle cancer	0.000997	0.00105	CcSEcCtD
Cevimeline—Constipation—Etoposide—muscle cancer	0.000997	0.00105	CcSEcCtD
Cevimeline—Dysuria—Doxorubicin—muscle cancer	0.000994	0.00105	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000988	0.00104	CcSEcCtD
Cevimeline—Haemoglobin—Methotrexate—muscle cancer	0.000988	0.00104	CcSEcCtD
Cevimeline—Diarrhoea—Vincristine—muscle cancer	0.000985	0.00104	CcSEcCtD
Cevimeline—Haemorrhage—Methotrexate—muscle cancer	0.000983	0.00104	CcSEcCtD
Cevimeline—Pollakiuria—Doxorubicin—muscle cancer	0.000982	0.00104	CcSEcCtD
Cevimeline—Pharyngitis—Methotrexate—muscle cancer	0.000975	0.00103	CcSEcCtD
Cevimeline—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00097	0.00103	CcSEcCtD
Cevimeline—Weight increased—Doxorubicin—muscle cancer	0.000968	0.00102	CcSEcCtD
Cevimeline—Urethral disorder—Methotrexate—muscle cancer	0.000963	0.00102	CcSEcCtD
Cevimeline—Weight decreased—Doxorubicin—muscle cancer	0.000962	0.00102	CcSEcCtD
Cevimeline—Feeling abnormal—Etoposide—muscle cancer	0.000961	0.00101	CcSEcCtD
Cevimeline—Hyperglycaemia—Doxorubicin—muscle cancer	0.000959	0.00101	CcSEcCtD
Cevimeline—Nausea—Dactinomycin—muscle cancer	0.000957	0.00101	CcSEcCtD
Cevimeline—Pneumonia—Doxorubicin—muscle cancer	0.000953	0.00101	CcSEcCtD
Cevimeline—Gastrointestinal pain—Etoposide—muscle cancer	0.000953	0.00101	CcSEcCtD
Cevimeline—Dizziness—Vincristine—muscle cancer	0.000952	0.00101	CcSEcCtD
Cevimeline—Visual impairment—Methotrexate—muscle cancer	0.000947	0.001	CcSEcCtD
Cevimeline—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000929	0.000982	CcSEcCtD
Cevimeline—Urticaria—Etoposide—muscle cancer	0.000926	0.000978	CcSEcCtD
Cevimeline—Stomatitis—Doxorubicin—muscle cancer	0.000924	0.000976	CcSEcCtD
Cevimeline—Abdominal pain—Etoposide—muscle cancer	0.000921	0.000973	CcSEcCtD
Cevimeline—Body temperature increased—Etoposide—muscle cancer	0.000921	0.000973	CcSEcCtD
Cevimeline—Urinary tract infection—Doxorubicin—muscle cancer	0.000921	0.000973	CcSEcCtD
Cevimeline—Conjunctivitis—Doxorubicin—muscle cancer	0.000921	0.000973	CcSEcCtD
Cevimeline—Eye disorder—Methotrexate—muscle cancer	0.000918	0.00097	CcSEcCtD
Cevimeline—Tinnitus—Methotrexate—muscle cancer	0.000916	0.000968	CcSEcCtD
Cevimeline—Vomiting—Vincristine—muscle cancer	0.000915	0.000966	CcSEcCtD
Cevimeline—Cardiac disorder—Methotrexate—muscle cancer	0.000912	0.000963	CcSEcCtD
Cevimeline—Rash—Vincristine—muscle cancer	0.000907	0.000958	CcSEcCtD
Cevimeline—Dermatitis—Vincristine—muscle cancer	0.000906	0.000957	CcSEcCtD
Cevimeline—Haematuria—Doxorubicin—muscle cancer	0.000904	0.000955	CcSEcCtD
Cevimeline—Headache—Vincristine—muscle cancer	0.000901	0.000952	CcSEcCtD
Cevimeline—Epistaxis—Doxorubicin—muscle cancer	0.000894	0.000944	CcSEcCtD
Cevimeline—Angiopathy—Methotrexate—muscle cancer	0.000892	0.000942	CcSEcCtD
Cevimeline—Sinusitis—Doxorubicin—muscle cancer	0.000889	0.000939	CcSEcCtD
Cevimeline—Agranulocytosis—Doxorubicin—muscle cancer	0.000885	0.000934	CcSEcCtD
Cevimeline—Chills—Methotrexate—muscle cancer	0.000882	0.000931	CcSEcCtD
Cevimeline—Alopecia—Methotrexate—muscle cancer	0.000868	0.000917	CcSEcCtD
Cevimeline—Hypersensitivity—Etoposide—muscle cancer	0.000859	0.000907	CcSEcCtD
Cevimeline—Malnutrition—Methotrexate—muscle cancer	0.000855	0.000904	CcSEcCtD
Cevimeline—Haemoglobin—Doxorubicin—muscle cancer	0.000855	0.000903	CcSEcCtD
Cevimeline—Nausea—Vincristine—muscle cancer	0.000855	0.000903	CcSEcCtD
Cevimeline—Rhinitis—Doxorubicin—muscle cancer	0.000853	0.000901	CcSEcCtD
Cevimeline—Haemorrhage—Doxorubicin—muscle cancer	0.000851	0.000899	CcSEcCtD
Cevimeline—CYP2D6—head—muscle cancer	0.000851	0.0159	CbGeAlD
Cevimeline—Hypoaesthesia—Doxorubicin—muscle cancer	0.000847	0.000894	CcSEcCtD
Cevimeline—Pharyngitis—Doxorubicin—muscle cancer	0.000845	0.000892	CcSEcCtD
Cevimeline—Oedema peripheral—Doxorubicin—muscle cancer	0.000838	0.000886	CcSEcCtD
Cevimeline—Dysgeusia—Methotrexate—muscle cancer	0.000838	0.000885	CcSEcCtD
Cevimeline—Asthenia—Etoposide—muscle cancer	0.000836	0.000883	CcSEcCtD
Cevimeline—Urethral disorder—Doxorubicin—muscle cancer	0.000834	0.000881	CcSEcCtD
Cevimeline—Back pain—Methotrexate—muscle cancer	0.000827	0.000874	CcSEcCtD
Cevimeline—Pruritus—Etoposide—muscle cancer	0.000825	0.000871	CcSEcCtD
Cevimeline—CYP2D6—testis—muscle cancer	0.000822	0.0154	CbGeAlD
Cevimeline—Visual impairment—Doxorubicin—muscle cancer	0.00082	0.000866	CcSEcCtD
Cevimeline—Diarrhoea—Etoposide—muscle cancer	0.000798	0.000842	CcSEcCtD
Cevimeline—Eye disorder—Doxorubicin—muscle cancer	0.000795	0.00084	CcSEcCtD
Cevimeline—Ill-defined disorder—Methotrexate—muscle cancer	0.000794	0.000838	CcSEcCtD
Cevimeline—Tinnitus—Doxorubicin—muscle cancer	0.000793	0.000838	CcSEcCtD
Cevimeline—Anaemia—Methotrexate—muscle cancer	0.000791	0.000835	CcSEcCtD
Cevimeline—Cardiac disorder—Doxorubicin—muscle cancer	0.00079	0.000834	CcSEcCtD
Cevimeline—Flushing—Doxorubicin—muscle cancer	0.00079	0.000834	CcSEcCtD
Cevimeline—Angiopathy—Doxorubicin—muscle cancer	0.000772	0.000816	CcSEcCtD
Cevimeline—Malaise—Methotrexate—muscle cancer	0.000771	0.000815	CcSEcCtD
Cevimeline—Dizziness—Etoposide—muscle cancer	0.000771	0.000814	CcSEcCtD
Cevimeline—Vertigo—Methotrexate—muscle cancer	0.000769	0.000812	CcSEcCtD
Cevimeline—Leukopenia—Methotrexate—muscle cancer	0.000766	0.000809	CcSEcCtD
Cevimeline—Chills—Doxorubicin—muscle cancer	0.000764	0.000807	CcSEcCtD
Cevimeline—Arrhythmia—Doxorubicin—muscle cancer	0.00076	0.000803	CcSEcCtD
Cevimeline—Alopecia—Doxorubicin—muscle cancer	0.000752	0.000794	CcSEcCtD
Cevimeline—Cough—Methotrexate—muscle cancer	0.000747	0.000789	CcSEcCtD
Cevimeline—Convulsion—Methotrexate—muscle cancer	0.000741	0.000783	CcSEcCtD
Cevimeline—Vomiting—Etoposide—muscle cancer	0.000741	0.000783	CcSEcCtD
Cevimeline—Malnutrition—Doxorubicin—muscle cancer	0.000741	0.000783	CcSEcCtD
Cevimeline—Rash—Etoposide—muscle cancer	0.000735	0.000776	CcSEcCtD
Cevimeline—Dermatitis—Etoposide—muscle cancer	0.000734	0.000776	CcSEcCtD
Cevimeline—Headache—Etoposide—muscle cancer	0.00073	0.000771	CcSEcCtD
Cevimeline—Flatulence—Doxorubicin—muscle cancer	0.00073	0.000771	CcSEcCtD
Cevimeline—Arthralgia—Methotrexate—muscle cancer	0.000728	0.000769	CcSEcCtD
Cevimeline—Chest pain—Methotrexate—muscle cancer	0.000728	0.000769	CcSEcCtD
Cevimeline—Myalgia—Methotrexate—muscle cancer	0.000728	0.000769	CcSEcCtD
Cevimeline—Dysgeusia—Doxorubicin—muscle cancer	0.000725	0.000766	CcSEcCtD
Cevimeline—Discomfort—Methotrexate—muscle cancer	0.00072	0.00076	CcSEcCtD
Cevimeline—Back pain—Doxorubicin—muscle cancer	0.000717	0.000757	CcSEcCtD
Cevimeline—Muscle spasms—Doxorubicin—muscle cancer	0.000712	0.000752	CcSEcCtD
Cevimeline—Confusional state—Methotrexate—muscle cancer	0.000704	0.000744	CcSEcCtD
Cevimeline—Infection—Methotrexate—muscle cancer	0.000694	0.000733	CcSEcCtD
Cevimeline—Nausea—Etoposide—muscle cancer	0.000692	0.000731	CcSEcCtD
Cevimeline—Ill-defined disorder—Doxorubicin—muscle cancer	0.000687	0.000726	CcSEcCtD
Cevimeline—Nervous system disorder—Methotrexate—muscle cancer	0.000685	0.000723	CcSEcCtD
Cevimeline—Anaemia—Doxorubicin—muscle cancer	0.000685	0.000723	CcSEcCtD
Cevimeline—Thrombocytopenia—Methotrexate—muscle cancer	0.000684	0.000722	CcSEcCtD
Cevimeline—Agitation—Doxorubicin—muscle cancer	0.000681	0.000719	CcSEcCtD
Cevimeline—Skin disorder—Methotrexate—muscle cancer	0.000678	0.000716	CcSEcCtD
Cevimeline—Hyperhidrosis—Methotrexate—muscle cancer	0.000675	0.000713	CcSEcCtD
Cevimeline—Malaise—Doxorubicin—muscle cancer	0.000668	0.000706	CcSEcCtD
Cevimeline—Vertigo—Doxorubicin—muscle cancer	0.000666	0.000703	CcSEcCtD
Cevimeline—Anorexia—Methotrexate—muscle cancer	0.000666	0.000703	CcSEcCtD
Cevimeline—Syncope—Doxorubicin—muscle cancer	0.000664	0.000702	CcSEcCtD
Cevimeline—Leukopenia—Doxorubicin—muscle cancer	0.000663	0.0007	CcSEcCtD
Cevimeline—Palpitations—Doxorubicin—muscle cancer	0.000655	0.000692	CcSEcCtD
Cevimeline—Hypotension—Methotrexate—muscle cancer	0.000652	0.000689	CcSEcCtD
Cevimeline—Loss of consciousness—Doxorubicin—muscle cancer	0.000651	0.000688	CcSEcCtD
Cevimeline—Cough—Doxorubicin—muscle cancer	0.000646	0.000683	CcSEcCtD
Cevimeline—Convulsion—Doxorubicin—muscle cancer	0.000642	0.000678	CcSEcCtD
Cevimeline—Hypertension—Doxorubicin—muscle cancer	0.00064	0.000676	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000636	0.000672	CcSEcCtD
Cevimeline—Insomnia—Methotrexate—muscle cancer	0.000631	0.000667	CcSEcCtD
Cevimeline—Myalgia—Doxorubicin—muscle cancer	0.000631	0.000666	CcSEcCtD
Cevimeline—Arthralgia—Doxorubicin—muscle cancer	0.000631	0.000666	CcSEcCtD
Cevimeline—Chest pain—Doxorubicin—muscle cancer	0.000631	0.000666	CcSEcCtD
Cevimeline—Anxiety—Doxorubicin—muscle cancer	0.000628	0.000664	CcSEcCtD
Cevimeline—Paraesthesia—Methotrexate—muscle cancer	0.000627	0.000662	CcSEcCtD
Cevimeline—Discomfort—Doxorubicin—muscle cancer	0.000623	0.000658	CcSEcCtD
Cevimeline—Dyspnoea—Methotrexate—muscle cancer	0.000622	0.000658	CcSEcCtD
Cevimeline—Somnolence—Methotrexate—muscle cancer	0.000621	0.000656	CcSEcCtD
Cevimeline—Dyspepsia—Methotrexate—muscle cancer	0.000615	0.000649	CcSEcCtD
Cevimeline—Confusional state—Doxorubicin—muscle cancer	0.00061	0.000644	CcSEcCtD
Cevimeline—Decreased appetite—Methotrexate—muscle cancer	0.000607	0.000641	CcSEcCtD
Cevimeline—Oedema—Doxorubicin—muscle cancer	0.000605	0.000639	CcSEcCtD
Cevimeline—Fatigue—Methotrexate—muscle cancer	0.000602	0.000636	CcSEcCtD
Cevimeline—Infection—Doxorubicin—muscle cancer	0.000601	0.000634	CcSEcCtD
Cevimeline—Pain—Methotrexate—muscle cancer	0.000597	0.000631	CcSEcCtD
Cevimeline—Shock—Doxorubicin—muscle cancer	0.000595	0.000628	CcSEcCtD
Cevimeline—Nervous system disorder—Doxorubicin—muscle cancer	0.000593	0.000626	CcSEcCtD
Cevimeline—Thrombocytopenia—Doxorubicin—muscle cancer	0.000592	0.000625	CcSEcCtD
Cevimeline—Tachycardia—Doxorubicin—muscle cancer	0.00059	0.000623	CcSEcCtD
Cevimeline—Skin disorder—Doxorubicin—muscle cancer	0.000587	0.00062	CcSEcCtD
Cevimeline—Hyperhidrosis—Doxorubicin—muscle cancer	0.000584	0.000617	CcSEcCtD
Cevimeline—Anorexia—Doxorubicin—muscle cancer	0.000576	0.000609	CcSEcCtD
Cevimeline—Feeling abnormal—Methotrexate—muscle cancer	0.000575	0.000608	CcSEcCtD
Cevimeline—Gastrointestinal pain—Methotrexate—muscle cancer	0.000571	0.000603	CcSEcCtD
Cevimeline—Hypotension—Doxorubicin—muscle cancer	0.000565	0.000597	CcSEcCtD
Cevimeline—Urticaria—Methotrexate—muscle cancer	0.000555	0.000586	CcSEcCtD
Cevimeline—Abdominal pain—Methotrexate—muscle cancer	0.000552	0.000583	CcSEcCtD
Cevimeline—Body temperature increased—Methotrexate—muscle cancer	0.000552	0.000583	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000551	0.000582	CcSEcCtD
Cevimeline—Insomnia—Doxorubicin—muscle cancer	0.000547	0.000578	CcSEcCtD
Cevimeline—Paraesthesia—Doxorubicin—muscle cancer	0.000543	0.000573	CcSEcCtD
Cevimeline—Dyspnoea—Doxorubicin—muscle cancer	0.000539	0.000569	CcSEcCtD
Cevimeline—Somnolence—Doxorubicin—muscle cancer	0.000537	0.000568	CcSEcCtD
Cevimeline—Dyspepsia—Doxorubicin—muscle cancer	0.000532	0.000562	CcSEcCtD
Cevimeline—Decreased appetite—Doxorubicin—muscle cancer	0.000526	0.000555	CcSEcCtD
Cevimeline—Fatigue—Doxorubicin—muscle cancer	0.000521	0.000551	CcSEcCtD
Cevimeline—Constipation—Doxorubicin—muscle cancer	0.000517	0.000546	CcSEcCtD
Cevimeline—Pain—Doxorubicin—muscle cancer	0.000517	0.000546	CcSEcCtD
Cevimeline—Hypersensitivity—Methotrexate—muscle cancer	0.000514	0.000543	CcSEcCtD
Cevimeline—Asthenia—Methotrexate—muscle cancer	0.000501	0.000529	CcSEcCtD
Cevimeline—Feeling abnormal—Doxorubicin—muscle cancer	0.000498	0.000526	CcSEcCtD
Cevimeline—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000494	0.000522	CcSEcCtD
Cevimeline—Pruritus—Methotrexate—muscle cancer	0.000494	0.000522	CcSEcCtD
Cevimeline—Urticaria—Doxorubicin—muscle cancer	0.00048	0.000507	CcSEcCtD
Cevimeline—Abdominal pain—Doxorubicin—muscle cancer	0.000478	0.000505	CcSEcCtD
Cevimeline—Body temperature increased—Doxorubicin—muscle cancer	0.000478	0.000505	CcSEcCtD
Cevimeline—Diarrhoea—Methotrexate—muscle cancer	0.000478	0.000505	CcSEcCtD
Cevimeline—Dizziness—Methotrexate—muscle cancer	0.000462	0.000488	CcSEcCtD
Cevimeline—Hypersensitivity—Doxorubicin—muscle cancer	0.000445	0.000471	CcSEcCtD
Cevimeline—Vomiting—Methotrexate—muscle cancer	0.000444	0.000469	CcSEcCtD
Cevimeline—Rash—Methotrexate—muscle cancer	0.00044	0.000465	CcSEcCtD
Cevimeline—Dermatitis—Methotrexate—muscle cancer	0.00044	0.000465	CcSEcCtD
Cevimeline—Headache—Methotrexate—muscle cancer	0.000437	0.000462	CcSEcCtD
Cevimeline—Asthenia—Doxorubicin—muscle cancer	0.000434	0.000458	CcSEcCtD
Cevimeline—Pruritus—Doxorubicin—muscle cancer	0.000428	0.000452	CcSEcCtD
Cevimeline—Nausea—Methotrexate—muscle cancer	0.000415	0.000438	CcSEcCtD
Cevimeline—Diarrhoea—Doxorubicin—muscle cancer	0.000414	0.000437	CcSEcCtD
Cevimeline—Dizziness—Doxorubicin—muscle cancer	0.0004	0.000422	CcSEcCtD
Cevimeline—Vomiting—Doxorubicin—muscle cancer	0.000384	0.000406	CcSEcCtD
Cevimeline—Rash—Doxorubicin—muscle cancer	0.000381	0.000403	CcSEcCtD
Cevimeline—Dermatitis—Doxorubicin—muscle cancer	0.000381	0.000402	CcSEcCtD
Cevimeline—Headache—Doxorubicin—muscle cancer	0.000379	0.0004	CcSEcCtD
Cevimeline—Nausea—Doxorubicin—muscle cancer	0.000359	0.000379	CcSEcCtD
